Enviro-Serv Debt/Equity
What is the Debt/Equity of Enviro-Serv?
The Debt/Equity of Enviro-Serv, Inc. is -0.60
What is the definition of Debt/Equity?
Debt to equity ratio is a financial ratio indicating the relative proportion of shareholders’ equity and debt used to finance a company’s assets.
lfy (last fiscal year)
The debt to equity ratio is generally calculated by dividing debt by equity. The D/E ratio is also known as risk, gearing or leverage. The two components are often taken from the firm's balance sheet or statement of financial position (so-called book value), but the ratio may also be calculated using market values for both, if the company's debt and equity are publicly traded, or using a combination of book value for debt and market value for equity financially. Preferred stock can be considered part of debt or equity. Attributing preferred shares to one or the other is partially a subjective decision but will also take into account the specific features of the preferred shares. When used to calculate a company's financial leverage, the debt usually includes only the long-term debt.
Debt/Equity of companies in the Industrials sector on OTC compared to Enviro-Serv
What does Enviro-Serv do?
Enviro-Serv, Inc. provides property maintenance services in the United States. It offers lawn/landscape maintenance and pest control services. The company was formerly known as Transfer Technology International Corp. and changed its name to Enviro-Serv, Inc. in March 2013 to reflect its new strategic corporate direction. Enviro-Serv, Inc. is based in Tampa, Florida.
Companies with debt/equity similar to Enviro-Serv
- Mechel PJSC has Debt/Equity of -0.79
- Catalyst Biosciences Inc has Debt/Equity of -0.78
- Paratek Pharmaceuticals has Debt/Equity of -0.72
- Vitro Diagnostics has Debt/Equity of -0.67
- Royale has Debt/Equity of -0.63
- McAfee has Debt/Equity of -0.61
- Enviro-Serv has Debt/Equity of -0.60
- Infinity Pharmaceuticals has Debt/Equity of -0.57
- Q BioMed has Debt/Equity of -0.51
- Bang has Debt/Equity of -0.51
- Invitae Corp has Debt/Equity of -0.49
- Inhibitor Therapeutics has Debt/Equity of -0.49
- Biostage has Debt/Equity of -0.44